Richard Narido
Directeur Financier/CFO chez NRX PHARMACEUTICALS, INC.
Fortune : - $ au 31/05/2024
Postes actifs de Richard Narido
Sociétés | Poste | Début | Fin |
---|---|---|---|
NRX PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 13/09/2023 | - |
Directeur Financier/CFO | 13/09/2023 | - |
Historique de carrière de Richard Narido
Anciens postes connus de Richard Narido
Sociétés | Poste | Début | Fin |
---|---|---|---|
LUCIRA HEALTH, INC. | Comptroller/Controller/Auditor | 15/11/2022 | - |
Directeur Financier/CFO | 15/11/2022 | 01/04/2023 | |
Corporate Officer/Principal | 01/03/2021 | - | |
ASSEMBLY BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/07/2018 | 01/03/2021 |
Directeur Financier/CFO | 01/07/2018 | 01/03/2021 | |
Treasurer | 01/07/2018 | 01/03/2021 | |
BIO-RAD LABORATORIES, INC. | Corporate Officer/Principal | 01/06/2014 | 01/06/2018 |
MCKESSON CORPORATION | Corporate Officer/Principal | 01/01/2006 | 01/11/2010 |
Formation de Richard Narido
University of San Francisco | Undergraduate Degree |
Pepperdine Graziadio Business School | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
2 |
Opérationnelle
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 3 |
Comptroller/Controller/Auditor | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
NRX PHARMACEUTICALS, INC. | Health Technology |
BIO-RAD LABORATORIES, INC. | Health Technology |
ASSEMBLY BIOSCIENCES, INC. | Health Technology |
MCKESSON CORPORATION | Distribution Services |
Entreprise privées | 1 |
---|---|
Lucira Health, Inc.
Lucira Health, Inc. Medical SpecialtiesHealth Technology Lucira Health, Inc. is a medical technology company, which engages in the business of developing and commercializing transformative and innovative infectious disease test kits. It operates through the following customer segments: the United States Healthcare (US Healthcare), United States Business to Business and Government (US Business to Business and Government), Direct to Consumer (DTC), and International. The US Healthcare segment provides solutions of choice for certain telehealth platforms and providers who are able to confirm diagnosis immediately and over a telehealth platform to drive treatment. The US Business to Business and Government segment is involved in selling OTC test kits to both employers and government organizations. The DTC segment includes selling directly to the individual consumer through online platforms. The International segment focuses on selling tests into Canada, Taiwan, Singapore, and Israel. The company was founded by Debkishore Mitra, John Robert Waldeisen, and Benjamin Ross on February 20, 2013 and is headquartered in Emeryville, CA. | Health Technology |
- Bourse
- Insiders
- Richard Narido
- Expérience